Jeffrey Allen at [NYU Langone Medical Center]

Jeffrey C. Allen, MD

  • Specialties: Pediatric Oncology, Pediatric Neurology, Pediatrics
  • Languages: English, French, Spanish
  • Phone: 212-263-8400

About Me

Conditions and Treatments

brain tumor, childhood cancer, brain cancer, neurofibromatosis, spinal cord tumor
Learn more about conditions we treat at NYU Langone:
Neurofibromatosis, Childhood Brain & Spinal Cord Tumors, Spinal Cord Tumors



  • Otto and Marguerite Manley and Making Headway Foundation Professor of Pediatric Neuro-Oncology, Department of Pediatrics
  • Professor, Department of Neurology

Board Certifications

  • AB Psychiatry & Neurology - Neurology
  • AB Psychiatry & Neurology - w/Spec Qual"s In Child Neurolo

Education and Training

  • 1976
  • Residency, Montreal Children's Hospital, Pediatrics
  • 1969
  • MD from Harvard Medical School


Locations and Appointments

64 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Healthy NY
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP Family Health
  • HIP Medicaid
  • HIP Medicare
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthRepublic
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • UPN Elite
  • United Exchange- Compass
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.

Stephen D. Hassenfeld Childrens Center for Cancer & Blood Disorders
160 East 32nd Street, 3rd Floor
New York, NY 10016


Phone: 212-263-8400

NYU Pediatric Oncology Associates
317 East 34th Street
New York, NY 10016


Phone: 212-263-8400

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Brain Tumor Research in Adults and Children

A Brain Tumor Research Center at NYU School of Medicine was established in 1992 with an award from the National Institute of Neurological Disorders and Stroke to support a tumor bank, a patient database, and five research projects concentrating on: 1) tumor suppressor genes in genetically high risk pediatric brain tumor populations, 2) interaction of recessive and dominant oncogenes, 3) growth factors, 4) cell adhesion molecules, and 5) cellular immunology. Currently, the tumor bank has accrued over 300 frozen human brain tumor specimens, and the patient database tracks over 1800 pediatric and 600 adult brain and spinal cord tumor patients. A new project in gene therapy of brain turnors, directed by Dan Mereulo, Ph.D., an NYU School of Medicine colleague, has secured longterm support from the National Institutes of Health.

The Brain Tumor Research Center also facilitates clinical research neuro-oncology protocols, both institutional and cooperative group trials, and actively engages in pharmaceutical collaborations.


  • The Cyclic AMP Pathway Is a Sex-Specific Modifier of Glioma Risk in Type I Neurofibromatosis Patients

    Warrington, Nicole M; Sun, Tao; Luo, Jingqin; McKinstry, Robert C; Parkin, Patricia C; Ganzhorn, Sara; Spoljaric, Debra; Albers, Anne C; Merkelson, Amanda; Stewart, Douglas R; Stevenson, David A; Viskochil, David; Druley, Todd E; Forys, Jason T; Reilly, Karlyne M; Fisher, Michael J; Tabori, Uri; Allen, Jeffrey C; Schiffman, Joshua D; Gutmann, David H; Rubin, Joshua B 2015 Jan; 16-21, Cancer research — id: 1450502, year: 2015, page: 16, stat: Journal Article
  • Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma

    Bartels, Ute; Wolff, Johannes; Gore, Lia; Dunkel, Ira; Gilheeney, Stephen; Allen, Jeffrey; Goldman, Stewart; Yalon, Michal; Packer, Roger J; Korones, David N; Smith, Amy; Cohen, Kenneth; Kuttesch, John; Strother, Douglas; Baruchel, Sylvain; Gammon, Janet; Kowalski, Mark; Bouffet, Eric 2014 Nov; 1554-1559, Neuro-oncology — id: 1315042, year: 2014, page: 1554, stat: Journal Article
  • Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas

    Karajannis, Matthias A; Legault, Genevieve; Fisher, Michael J; Milla, Sarah S; Cohen, Kenneth J; Wisoff, Jeffrey H; Harter, David H; Goldberg, Judith D; Hochman, Tsivia; Merkelson, Amanda; Bloom, Michael C; Sievert, Angela J; Resnick, Adam C; Dhall, Girish; Jones, David T W; Korshunov, Andrey; Pfister, Stefan M; Eberhart, Charles G; Zagzag, David; Allen, Jeffrey C 2014 May; 57-62, Neuro-oncology — id: 959362, year: 2014, page: 57, stat: JOURNAL ARTICLE
Read All Publications (314)